Erectile Dysfunction Due to Arterial Insufficiency Clinical Trial
Official title:
Incidence of Male Pudendal Artery Stenosis in Suboptimal Erections Study
The purpose of this study is to determine the proportion of men with known or suspected coronary artery disease (CAD) and/or peripheral arterial disease (PAD) that have angiographic identifiable erectile related artery (ERA) atherosclerotic disease defined as at least one ERA stenosis greater than or equal to 50% (per core lab Quantitative Vascular Analysis - QVA).
Vascular insufficiency is a commonly cited cause of Erectile Dysfunction (ED) and the most
common treatments of ED target aspects of the penile vasculature. Initial pharmacotherapy
typically focuses on the penile microvasculature; however, surgical revascularization has
also been used to treat ED caused by lesions in the internal iliac artery (IIA) and/or
internal pudendal artery (IPA) and penile arteries. Anatomically, surgical revascularization
connects the inferior epigastric artery to the dorsal artery of the penis or a combination
of the dorsal artery and vein of the penis. The pudendal artery or deep artery of the penis
is usually not the target of surgical bypass. Recent advances in percutaneous
revascularization have sparked interest in penile revascularization to treat ED.
However, as this new percutaneous treatment modality evolves, several important clinical
questions remain unanswered. Important among these are what is the normal angiographic
anatomy of the erectile related arteries (ERA), and how do angiographic findings correlate
with symptoms of ED? Also, how many men could possible benefit from percutaneous
revascularization?
The normal IPA anatomy by contrast angiography is not well defined and there are no studies
that correlate IPA findings with erectile function. While studies have been done on
populations of men with suspected vasculogenic and chronic ED, no study has established the
normal angiographic anatomy of the IPA or evaluated the prevalence of angiographic IPA
occlusive disease.
Therefore, an angiographic prevalence study will assist in determining the population of men
who could potentially benefit from percutaneous treatment of atherosclerotic IPA lesions.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04050020 -
Platelet-rich Plasma (PRP) Injection for Treatment of Erectile Function
|
Phase 2/Phase 3 | |
Recruiting |
NCT05868668 -
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
|
N/A | |
Active, not recruiting |
NCT04434352 -
Low Intensity Shockwave Therapy for Erectile Dysfunction
|
N/A |